| 000 | 01443 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514015054.0 | ||
| 264 | 0 | _c20020213 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1262-3636 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharpentier, G | |
| 245 | 0 | 0 |
_aPredictors of response to glimepiride in patients with type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDiabetes & metabolism _cNov 2001 |
||
| 300 |
_a563-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aApolipoproteins _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xphysiopathology |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
| 700 | 1 | _aVaur, L | |
| 700 | 1 | _aHalimi, S | |
| 700 | 1 | _aFleury, F | |
| 700 | 1 | _aDerobert, E | |
| 700 | 1 | _aGrimaldi, A | |
| 700 | 1 | _aOriol, V | |
| 700 | 1 | _aEtienne, S | |
| 700 | 1 | _aAltman, J J | |
| 773 | 0 |
_tDiabetes & metabolism _gvol. 27 _gno. 5 Pt 1 _gp. 563-71 |
|
| 999 |
_c11610451 _d11610451 |
||